Veerhealth Care Ltd (NIYATILEAS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 631680,
    "name": "Veerhealth Care",
    "stock_name": "Veerhealth Care",
    "full_name": "Veerhealth Care Ltd",
    "name_url": "stocks-analysis/veerhealth-care",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "17.88",
    "chg": -0.85,
    "chgp": "-4.54%",
    "dir": -1,
    "prev_price": "18.73",
    "mcapval": "38.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 511523,
    "symbol": "NIYATILEAS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE882C01035",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.11 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/veerhealth-care-631680-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Veerhealth Care Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/veerhealth-care-stock-upgraded-from-strong-sell-to-sell-amid-mixed-financial-and-technical-signals-3732573",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VeerhealthCare_mojoScore_3732573.png",
        "date": "2025-11-27 08:07:34",
        "description": "Veerhealth Care, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in market assessment driven by a combination of technical indicators and financial performance metrics. Despite recent positive quarterly results, the company’s long-term fundamentals and valuation metrics present a complex picture for investors navigating the current market environment."
      },
      {
        "title": "Why is Veerhealth Care falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-veerhealth-care-fallingrising-3732122",
        "imagepath": "",
        "date": "2025-11-27 00:36:34",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Strong Outperformance Against Sector and Benchmark</strong></p>\n<p>Veerhealth Care’s performance on 26 Nov stands out distinctly when compared to both its sector and the broader market. The stock outperformed its sector by 8.92%, a substantial margin that highlights its relative strength. Over the past week, the stock has gained 6.56%, far exceeding the Sensex’s modest 0.50% rise during the same period. This outperformance suggests that investors are favouring Veerhealth Care amid a generally subdued market environment.</p>\n<p>The stock’s one-month return of 2.69% also surpasses the Sensex’s 1.66%, reinforcing the notion that Veerhealth Care is attracting sustained buying interest. However, it is important to note that on a year-to-date basis, the stock remains down by 5.18%, contrasting wit..."
      },
      {
        "title": "How has been the historical performance of Veerhealth Care?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-veerhealth-care-3731954",
        "imagepath": "",
        "date": "2025-11-26 22:43:56",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue Growth and Operating Performance</strong></p>\n<p>Veerhealth Care’s net sales have shown a consistent upward trend, rising from ₹5.98 crores in March 2019 to ₹16.67 crores in March 2025. This represents a near threefold increase over six years, reflecting the company’s expanding market presence and sales capabilities. The total operating income mirrors this growth, as other operating income remained nil throughout the period, indicating that revenue is primarily driven by core business activities.</p>\n<p>Despite this growth, the company’s operating profit margin excluding other income has experienced volatility. After a peak margin of 7.36% in 2019, margins declined sharply to negative territory in 2022, before recovering modestly to 2.76% in 2025. This fluctuation suggests challenges..."
      },
      {
        "title": "Are Veerhealth Care latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-veerhealth-care-latest-results-good-or-bad-3698334",
        "imagepath": "",
        "date": "2025-11-13 19:32:21",
        "description": "Veerhealth Care's latest financial results for Q2 FY26 present a complex picture of its operational performance. The company reported net sales of ₹3.98 crores, reflecting a contraction of 11.36% compared to the previous quarter and a significant decline of 22.72% year-on-year. This persistent revenue decline highlights ongoing challenges in maintaining market traction, particularly in a competitive pharmaceutical landscape.\n\nOn the profitability front, Veerhealth Care achieved a net profit of ₹0.25 crores, which represents a slight increase of 4.17% from the previous quarter, although it is down 16.67% from the same period last year. The profit after tax margin improved to 6.28%, up from 5.35% in Q1 FY26, indicating some progress in cost management. However, the reliance on other income, which accounted for a notable portion of the operating profit, raises concerns about the sustainability of these profita..."
      },
      {
        "title": "Veerhealth Care Q2 FY26: Profit Recovery Masks Deeper Revenue Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/veerhealth-care-q2-fy26-profit-recovery-masks-deeper-revenue-concerns-3698174",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VeerhealthCare_quaterlyResult_3698174.png",
        "date": "2025-11-13 09:31:17",
        "description": "Veerhealth Care Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹35.60 crores, reported a net profit of ₹0.25 crores in Q2 FY26, marking a marginal 4.17% quarter-on-quarter increase but a concerning 16.67% year-on-year decline. The stock, currently trading at ₹17.80, has struggled with a mildly bearish technical trend and remains 25.12% below its 52-week high of ₹23.77, reflecting investor scepticism about the company's ability to sustain profitable growth amidst persistent revenue volatility."
      },
      {
        "title": "How has been the historical performance of Veerhealth Care?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-veerhealth-care-3695282",
        "imagepath": "",
        "date": "2025-11-13 00:14:34",
        "description": "Answer:\nThe historical performance of Veerhealth Care shows a fluctuating trend in key financial metrics over the years.\n\nBreakdown:\nVeerhealth Care's net sales have shown a steady increase from INR 5.98 crore in March 2019 to INR 16.67 crore in March 2025, with a notable rise from INR 13.22 crore in March 2024. The total operating income followed a similar trajectory, reaching INR 16.67 crore in March 2025. Total expenditure, excluding depreciation, also rose to INR 16.21 crore in March 2025, up from INR 12.61 crore in the previous year. Operating profit (PBDIT) was INR 1.68 crore in March 2025, a decrease from INR 2.00 crore in March 2024. Profit before tax was INR 0.51 crore in March 2025, down from INR 1.28 crore in March 2024, while profit after tax slightly decreased to INR 0.39 crore from INR 0.41 crore. The company's total assets increased to INR 33.77 crore in March 2025, compared to INR 28.12 cror..."
      },
      {
        "title": "How has been the historical performance of Veerhealth Care?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-veerhealth-care-3693848",
        "imagepath": "",
        "date": "2025-11-12 23:15:37",
        "description": "Answer:\nThe historical performance of Veerhealth Care shows a fluctuating trend in its financial metrics over the years, with notable changes in revenue and profit margins.\n\nBreakdown:\nVeerhealth Care's net sales have increased from 9.63 Cr in Mar'22 to 16.67 Cr in Mar'25, reflecting a strong growth trajectory. Total operating income followed a similar pattern, rising from 9.63 Cr in Mar'22 to 16.67 Cr in Mar'25. The company's total expenditure also increased, reaching 16.21 Cr in Mar'25 from 10.45 Cr in Mar'22. Operating profit, excluding other income, was 0.46 Cr in Mar'25, down from 0.61 Cr in Mar'24, while the overall operating profit (PBDIT) was 1.68 Cr in Mar'25, a decrease from 2.00 Cr in Mar'24. Profit before tax showed a decline to 0.51 Cr in Mar'25 from 1.28 Cr in Mar'24, and profit after tax was 0.39 Cr in Mar'25, slightly down from 0.41 Cr in Mar'24. The company's total assets grew to 33.77 Cr i..."
      },
      {
        "title": "Veerhealth Care Faces Mixed Technical Signals Amidst Financial Challenges and Recent Growth",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/veerhealth-care-stock-downgraded-to-strong-sell-amid-bearish-trends-3688569",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VeerhealthCare_mojoScore_3688569.png",
        "date": "2025-11-11 08:25:49",
        "description": "Veerhealth Care, a microcap in the Pharmaceuticals & Biotechnology sector, has recently adjusted its evaluation score, reflecting a shift in technical trends. Despite reporting positive financial performance for Q1 FY25-26, the company faces challenges with operating losses and low profitability, contributing to its underperformance compared to the broader market."
      },
      {
        "title": "Why is Veerhealth Care falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-veerhealth-care-fallingrising-3680858",
        "imagepath": "",
        "date": "2025-11-07 22:29:29",
        "description": "As of 07-Nov, Veerhealth Care Ltd's stock price is currently at 17.88, reflecting a decrease of 0.22, or 1.22%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 4.94% during this period. Additionally, the stock's performance over the past month shows a decline of 4.03%, and year-to-date, it has decreased by 9.28%. The stock is currently trading higher than its 200-day moving average but lower than its 5-day, 20-day, 50-day, and 100-day moving averages. Furthermore, there has been a significant drop in investor participation, with delivery volume falling by 59.59% compared to the 5-day average, indicating reduced interest from investors.\n\nIn the broader market context, the Sensex has shown a decline of 0.86% over the past week, which is less than the stock's own weekly decline of 0.11%. This suggests that while the stock is underperformi..."
      }
    ],
    "total": 139,
    "sid": "631680",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/veerhealth-care-631680"
  },
  "announcements": [
    {
      "caption": "Appointment of Company Secretary and Compliance Officer",
      "datetime": "02-Feb-2026",
      "details": "This is to inform you that Ms. Ashita Chittora is appoitned as a Company Secretary with effect from 02.02.2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Appointment Of Company Sceretary",
      "datetime": "02-Feb-2026",
      "details": "Appointment of CS",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "30-Jan-2026",
      "details": "Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 we are hereby submitting the certificate received from our RTA.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Veerhealth Care Ltd has announced <strong>10:1</strong> stock split, ex-date: 29 Nov 16",
          "dt": "2016-11-29",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Veerhealth Care Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 22 Sep 23",
          "dt": "2023-09-22",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Veerhealth Care Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals

2025-11-27 08:07:34

Veerhealth Care, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in market assessment driven by a combination of technical indicators and financial performance metrics. Despite recent positive quarterly results, the company’s long-term fundamentals and valuation metrics present a complex picture for investors navigating the current market environment.

Why is Veerhealth Care falling/rising?

2025-11-27 00:36:34

Strong Outperformance Against Sector and Benchmark Veerhealth Care’s performance on 26 Nov stands out distinctly when compared to both its sector and the broader market. The stock outperformed its sector by 8.92%, a substantial margin that highlights its relative strength. Over the past week, the stock has gained 6.56%, far exceeding the Sensex’s modest 0.50% rise during the same period. This outperformance suggests that investors are favouring Veerhealth Care amid a generally subdued market environment. The stock’s one-month return of 2.69% also surpasses the Sensex’s 1.66%, reinforcing the notion that Veerhealth Care is attracting sustained buying interest. However, it is important to note that on a year-to-date basis, the stock remains down by 5.18%, contrasting wit...

How has been the historical performance of Veerhealth Care?

2025-11-26 22:43:56

Revenue Growth and Operating Performance Veerhealth Care’s net sales have shown a consistent upward trend, rising from ₹5.98 crores in March 2019 to ₹16.67 crores in March 2025. This represents a near threefold increase over six years, reflecting the company’s expanding market presence and sales capabilities. The total operating income mirrors this growth, as other operating income remained nil throughout the period, indicating that revenue is primarily driven by core business activities. Despite this growth, the company’s operating profit margin excluding other income has experienced volatility. After a peak margin of 7.36% in 2019, margins declined sharply to negative territory in 2022, before recovering modestly to 2.76% in 2025. This fluctuation suggests challenges...

Are Veerhealth Care latest results good or bad?

2025-11-13 19:32:21

Veerhealth Care's latest financial results for Q2 FY26 present a complex picture of its operational performance. The company reported net sales of ₹3.98 crores, reflecting a contraction of 11.36% compared to the previous quarter and a significant decline of 22.72% year-on-year. This persistent revenue decline highlights ongoing challenges in maintaining market traction, particularly in a competitive pharmaceutical landscape. On the profitability front, Veerhealth Care achieved a net profit of ₹0.25 crores, which represents a slight increase of 4.17% from the previous quarter, although it is down 16.67% from the same period last year. The profit after tax margin improved to 6.28%, up from 5.35% in Q1 FY26, indicating some progress in cost management. However, the reliance on other income, which accounted for a notable portion of the operating profit, raises concerns about the sustainability of these profita...

Veerhealth Care Q2 FY26: Profit Recovery Masks Deeper Revenue Concerns

2025-11-13 09:31:17

Veerhealth Care Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹35.60 crores, reported a net profit of ₹0.25 crores in Q2 FY26, marking a marginal 4.17% quarter-on-quarter increase but a concerning 16.67% year-on-year decline. The stock, currently trading at ₹17.80, has struggled with a mildly bearish technical trend and remains 25.12% below its 52-week high of ₹23.77, reflecting investor scepticism about the company's ability to sustain profitable growth amidst persistent revenue volatility.

How has been the historical performance of Veerhealth Care?

2025-11-13 00:14:34

Answer: The historical performance of Veerhealth Care shows a fluctuating trend in key financial metrics over the years. Breakdown: Veerhealth Care's net sales have shown a steady increase from INR 5.98 crore in March 2019 to INR 16.67 crore in March 2025, with a notable rise from INR 13.22 crore in March 2024. The total operating income followed a similar trajectory, reaching INR 16.67 crore in March 2025. Total expenditure, excluding depreciation, also rose to INR 16.21 crore in March 2025, up from INR 12.61 crore in the previous year. Operating profit (PBDIT) was INR 1.68 crore in March 2025, a decrease from INR 2.00 crore in March 2024. Profit before tax was INR 0.51 crore in March 2025, down from INR 1.28 crore in March 2024, while profit after tax slightly decreased to INR 0.39 crore from INR 0.41 crore. The company's total assets increased to INR 33.77 crore in March 2025, compared to INR 28.12 cror...

How has been the historical performance of Veerhealth Care?

2025-11-12 23:15:37

Answer: The historical performance of Veerhealth Care shows a fluctuating trend in its financial metrics over the years, with notable changes in revenue and profit margins. Breakdown: Veerhealth Care's net sales have increased from 9.63 Cr in Mar'22 to 16.67 Cr in Mar'25, reflecting a strong growth trajectory. Total operating income followed a similar pattern, rising from 9.63 Cr in Mar'22 to 16.67 Cr in Mar'25. The company's total expenditure also increased, reaching 16.21 Cr in Mar'25 from 10.45 Cr in Mar'22. Operating profit, excluding other income, was 0.46 Cr in Mar'25, down from 0.61 Cr in Mar'24, while the overall operating profit (PBDIT) was 1.68 Cr in Mar'25, a decrease from 2.00 Cr in Mar'24. Profit before tax showed a decline to 0.51 Cr in Mar'25 from 1.28 Cr in Mar'24, and profit after tax was 0.39 Cr in Mar'25, slightly down from 0.41 Cr in Mar'24. The company's total assets grew to 33.77 Cr i...

Veerhealth Care Faces Mixed Technical Signals Amidst Financial Challenges and Recent Growth

2025-11-11 08:25:49

Veerhealth Care, a microcap in the Pharmaceuticals & Biotechnology sector, has recently adjusted its evaluation score, reflecting a shift in technical trends. Despite reporting positive financial performance for Q1 FY25-26, the company faces challenges with operating losses and low profitability, contributing to its underperformance compared to the broader market.

Why is Veerhealth Care falling/rising?

2025-11-07 22:29:29

As of 07-Nov, Veerhealth Care Ltd's stock price is currently at 17.88, reflecting a decrease of 0.22, or 1.22%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 4.94% during this period. Additionally, the stock's performance over the past month shows a decline of 4.03%, and year-to-date, it has decreased by 9.28%. The stock is currently trading higher than its 200-day moving average but lower than its 5-day, 20-day, 50-day, and 100-day moving averages. Furthermore, there has been a significant drop in investor participation, with delivery volume falling by 59.59% compared to the 5-day average, indicating reduced interest from investors. In the broader market context, the Sensex has shown a decline of 0.86% over the past week, which is less than the stock's own weekly decline of 0.11%. This suggests that while the stock is underperformi...

View All News